Cancer-Associated Fibroblasts: Enablers of Tumor Drug Resistance

The authors integrate recent literature and synthesize evidence from both preclinical and clinical studies to elucidate the potential mechanisms by which cancer-associated fibroblasts (CAFs) contribute to therapeutic resistance and to summarize up-to-date research developments in nanotherapeutic strategies targeting CAFs.